{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:36:24Z","timestamp":1790944584876,"version":"4.1.0"},"reference-count":113,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>NKT cells comprise three subsets\u2014type I (invariant, iNKT), type II, and NKT-like cells, of which iNKT cells are the most studied subset. They are capable of rapid cytokine production after the initial stimulus, thus they may be important for polarisation of Th cells. Due to this, they may be an important cell subset in autoimmune diseases. In the current review, we are summarising results of NKT-oriented studies in major neurological autoimmune diseases\u2014multiple sclerosis, myasthenia gravis, and Guillain-Barre syndrome and their corresponding animal models.<\/jats:p>","DOI":"10.3390\/ijms22179520","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:02:11Z","timestamp":1630576931000},"page":"9520","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases\u2014Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-6353","authenticated-orcid":false,"given":"Micha\u0142 K.","family":"Zarobkiewicz","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-8779","authenticated-orcid":false,"given":"Izabela","family":"Morawska","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9598-373X","authenticated-orcid":false,"given":"Adam","family":"Michalski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Roli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2340-9442","authenticated-orcid":false,"given":"Agnieszka","family":"Bojarska-Junak","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5604\/17322693.1034001","article-title":"{NKT cells: Their development, mechanisms and effects of action}","volume":"67","author":"Tabarkiewicz","year":"2013","journal-title":"Postepy Hig. Med. Dosw."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: What\u2019s in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The Biology of NKT Cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imm.12958","article-title":"The interaction between invariant Natural Killer T cells and the mucosal microbiota","volume":"155","author":"Hapil","year":"2018","journal-title":"Immunology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1084\/jem.20031389","article-title":"Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide","volume":"199","author":"Jahng","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Torina, A., Guggino, G., La Manna, M.P., and Sireci, G. (2018). The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201801.0189.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.1841","article-title":"Raising the NKT cell family","volume":"11","author":"Godfrey","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.182.6.2091","article-title":"Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes","volume":"182","author":"Bendelac","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.12688\/f1000research.21378.1","article-title":"Recent advances in iNKT cell development","volume":"9","author":"Hogquist","year":"2020","journal-title":"F1000Research"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ni.3047","article-title":"Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue","volume":"16","author":"Lynch","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molimm.2020.12.005","article-title":"Reading the room: iNKT cells influence B cell responses","volume":"130","author":"Leadbetter","year":"2021","journal-title":"Mol. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Basabe, A., Strati, F., and Facciotti, F. (2020). License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113909"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11684-018-0622-3","article-title":"NKT cells in liver diseases","volume":"12","author":"Zhu","year":"2018","journal-title":"Front. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1084\/jem.194.12.1801","article-title":"Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis","volume":"194","author":"Singh","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.4049\/jimmunol.168.12.6007","article-title":"Cutting Edge: V\u03b114\u2212J\u03b1281 NKT Cells Naturally Regulate Experimental Autoimmune Encephalomyelitis in Nonobese Diabetic Mice","volume":"168","author":"Mars","year":"2002","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nowak, M., and Schmidt-Wolf, I.G. (2011). Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy. Cancers, 3.","DOI":"10.3390\/cancers3033661"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2018.08.010","article-title":"Natural killer T cells and ulcerative colitis","volume":"335","author":"Lai","year":"2019","journal-title":"Cell. Immunol."},{"key":"ref_18","first-page":"2S21","article-title":"NKT-like cells are expanded in solid tumour patients","volume":"25","author":"Valik","year":"2012","journal-title":"Klin. Onkol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fimmu.2016.00617","article-title":"Steroid Resistant CD8+CD28null NKT-like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease","volume":"7","author":"Hodge","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1468-1331.2006.01342.x","article-title":"The epidemiology of multiple sclerosis in Europe","volume":"13","author":"Pugliatti","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"a029025","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T Cells in Multiple Sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2567.2007.02655.x","article-title":"Innate immunity modulates autoimmunity: Type 1 interferon-\u03b2 treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation","volume":"122","author":"Gigli","year":"2007","journal-title":"Immunology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2008.07.007","article-title":"T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to \u03b1-galactosylceramide are impaired","volume":"275","author":"Gately","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/intimm\/dxg029","article-title":"Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission","volume":"15","author":"Araki","year":"2003","journal-title":"Int. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/clim.2001.5060","article-title":"Circulating V\u03b124+ V\u03b211+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage","volume":"100","author":"Nishia","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.imlet.2003.09.014","article-title":"A biased V\u03b124+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease","volume":"90","author":"Gachelin","year":"2003","journal-title":"Immunol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.164.8.4375","article-title":"Differential Expression of NK T Cell V\u03b124J\u03b1Q Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy","volume":"164","author":"Kondo","year":"2000","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"577046","DOI":"10.1016\/j.jneuroim.2019.577046","article-title":"ROR\u03b3T is overexpressed in iNKT and \u03b3\u03b4 T cells during relapse in relapsing-remitting multiple sclerosis","volume":"337","author":"Zarobkiewicz","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/clim.2000.4942","article-title":"Decreases in Interleukin-4 Secretion by Invariant CD4\u2212CD8\u2212V\u03b124J\u03b1Q T Cells in Peripheral Blood of Patients with Relapsing\u2013Remitting Multiple Sclerosis","volume":"98","author":"Gausling","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1191\/1352458504ms1070oa","article-title":"Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1\/Th2 balance and NKT cell subset in multiple sclerosis","volume":"10","author":"Feng","year":"2004","journal-title":"Mult. Scler. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"577065","DOI":"10.1016\/j.jneuroim.2019.577065","article-title":"Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients","volume":"337","author":"Altunrende","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2008.02.003","article-title":"CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis","volume":"31","author":"McKay","year":"2008","journal-title":"J. Autoimmun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jneuroim.2016.09.004","article-title":"Early hematopoiesis in multiple sclerosis patients","volume":"299","author":"Jons","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cei.12125","article-title":"Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis","volume":"173","author":"Sellner","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fimmu.2019.00515","article-title":"Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies","volume":"10","author":"Heming","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cei.12580","article-title":"Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis","volume":"180","author":"Alenda","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_39","first-page":"196","article-title":"Activation of Blood CD3+CD56+CD8+ T Cells during Pregnancy and Multiple Sclerosis","volume":"8","author":"Alonso","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Clerico, M., Artusi, C.A., Di Liberto, A., Rolla, S., Bardina, V., Barbero, P., De Mercanti, S.F., and Durelli, L. (2017). Natalizumab in Multiple Sclerosis: Long-Term Management. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050940"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1080\/14656566.2017.1373093","article-title":"Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis","volume":"18","author":"Thomas","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Harrer, A., Pilz, G., Einhaeupl, M., Oppermann, K., Hitzl, W., Wipfler, P., Sellner, J., Golaszewski, S., Afazel, S., and Haschke-Becher, E. (2012). Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab\u2014A Flow Cytometric Study on Patients with Multiple Sclerosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031784"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2019.01.007","article-title":"Factors associated with dimethyl fumarate-induced lymphopenia","volume":"398","author":"Medina","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/acn3.51206","article-title":"Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS","volume":"7","author":"Moser","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: Experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.4049\/jimmunol.1003916","article-title":"Invariant NKT Cells Producing IL-4 or IL-10, But Not IFN-\u03b3, Inhibit the Th1 Response in Experimental Autoimmune Encephalomyelitis, Whereas None of These Cells Inhibits the Th17 Response","volume":"186","author":"Oh","year":"2011","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.188.10.1875","article-title":"CD4(+) T Cells Prevent Spontaneous Experimental Autoimmune Encephalomyelitis in Anti-Myelin Basic Protein T Cell Receptor Transgenic Mice","volume":"188","author":"Tonegawa","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4049\/jimmunol.1103608","article-title":"Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6ChiInflammatory Monocyte to M2 Macrophages and Improved Outcome","volume":"189","author":"Denney","year":"2012","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/imcb.1031","article-title":"GPR65 inhibits experimental autoimmune encephalomyelitis through CD4+ T cell independent mechanisms that include effects on iNKT cells","volume":"96","author":"Wirasinha","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.181.4.2321","article-title":"Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner","volume":"181","author":"Mars","year":"2008","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.194.12.1789","article-title":"Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis","volume":"194","author":"Jahng","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_53","first-page":"531","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.4049\/jimmunol.1201718","article-title":"Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells","volume":"190","author":"Parekh","year":"2013","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.200323885","article-title":"Activation of invariant NKT cells by \u03b1GalCer administration protects mice from MOG35\u201355-induced EAE: Critical roles for administration route and IFN-\u03b3","volume":"33","author":"Furlan","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.4049\/jimmunol.1302898","article-title":"Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis","volume":"193","author":"Maricic","year":"2014","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.178.8.4908","article-title":"Interdependency of MHC class II\/self-peptide and CD1d\/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity","volume":"178","author":"Wiethe","year":"2007","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/intimm\/dxu147","article-title":"NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice","volume":"27","author":"Waddell","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.172.1.186","article-title":"CD1-Dependent Regulation of Chronic Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis","volume":"172","author":"Teige","year":"2004","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4049\/jimmunol.166.1.662","article-title":"Costimulation-Dependent Modulation of Experimental Autoimmune Encephalomyelitis by Ligand Stimulation of V\u03b114 NK T Cells","volume":"166","author":"Pal","year":"2001","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.tins.2020.06.002","article-title":"The Gut\u2013CNS Axis in Multiple Sclerosis","volume":"43","author":"Kadowaki","year":"2020","journal-title":"Trends Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2353\/ajpath.2008.080622","article-title":"NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora","volume":"173","author":"Yokote","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13293-021-00358-3","article-title":"The role of vitamin D in autoimmune diseases: Could sex make the difference?","volume":"12","author":"Dupuis","year":"2021","journal-title":"Biol. Sex Differ."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e98773","DOI":"10.1172\/jci.insight.98773","article-title":"1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites","volume":"3","author":"Wasnik","year":"2018","journal-title":"JCI Insight"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/1753425917721965","article-title":"The influence of vitamin D on M1 and M2 macrophages in patients with Crohn\u2019s disease","volume":"23","author":"Dionne","year":"2017","journal-title":"Innate Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2007.02.017","article-title":"Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCR\u03b1\u03b2+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE)","volume":"28","author":"Tutaj","year":"2007","journal-title":"J. Autoimmun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1344","article-title":"Lipid microarrays identify key mediators of autoimmune brain inflammation","volume":"12","author":"Kanter","year":"2005","journal-title":"Nat. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Brandl, C., Ortler, S., Herrmann, T., Cardell, S., Lutz, M.B., and Wiendl, H. (2010). B7-H1-Deficiency Enhances the Potential of Tolerogenic Dendritic Cells by Activating CD1d Restricted Type II NKT Cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010800"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: A supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.autrev.2013.03.002","article-title":"Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens","volume":"12","author":"Zisimopoulou","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1375\/twin.9.4.573","article-title":"Familial Risks for Diseases of Myoneural Junction and Muscle in Siblings Based on Hospitalizations and Deaths in Sweden","volume":"9","author":"Hemminki","year":"2006","journal-title":"Twin Res. Hum. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1375\/twin.14.2.129","article-title":"Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis","volume":"14","author":"Ramanujam","year":"2011","journal-title":"Twin Res. Hum. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1212\/01.wnl.0000312514.66164.88","article-title":"Familial Occurrence of Autoimmune Myasthenia Gravis with Different Antibody Specificity","volume":"70","author":"Lavrnic","year":"2008","journal-title":"Neurology"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Carr, A.S., Cardwell, C., McCarron, P.O., and McConville, J. (2010). A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol., 10.","DOI":"10.1186\/1471-2377-10-46"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: Innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4103\/0301-4738.145987","article-title":"Ocular myasthenia gravis: A review","volume":"62","author":"Venkatramani","year":"2014","journal-title":"Indian J. Ophthalmol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.64.1.78","article-title":"Mortality and survival in myasthenia gravis: A Danish population based study","volume":"64","author":"Christensen","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Bismuth","year":"2010","journal-title":"Autoimmunity"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jneuroim.2008.07.012","article-title":"Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience","volume":"201\u2013202","author":"Maggi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis\u2014Pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2005.09.010","article-title":"Genetics of autoimmune myasthenia gravis: The multifaceted contribution of the HLA complex","volume":"25","author":"Vandiedonck","year":"2005","journal-title":"J. Autoimmun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/intimm\/12.10.1381","article-title":"Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis","volume":"12","author":"Wang","year":"2000","journal-title":"Int. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.humimm.2007.02.003","article-title":"Polymorphisms of interferon-\u03b3, interleukin-10, and interleukin-12 genes in myasthenia gravis","volume":"68","author":"Yilmaz","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1093\/hmg\/ddn246","article-title":"Autoimmune diseases: Insights from genome-wide association studies","volume":"17","author":"Lettre","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential Estrogen Receptor Expression in Autoimmune Myasthenia Gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2012.12.005","article-title":"Infectome: A platform to trace infectious triggers of autoimmunity","volume":"12","author":"Bogdanos","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: Triggers of or triggered by autoimmunity?","volume":"9","author":"Getts","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Padberg","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0167-5699(95)80095-6","article-title":"The basis of autoimmunity: Part I mechanisms of aberrant self-recognition","volume":"16","author":"Theofilopoulos","year":"1995","journal-title":"Immunol. Today"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.coi.2003.09.014","article-title":"Natural killer T cells: Natural or unnatural regulators of autoimmunity?","volume":"15","author":"Hammond","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.4049\/jimmunol.174.11.6764","article-title":"A Defect in Lineage Fate Decision during Fetal Thymic Invariant NKT Cell Development May Regulate Susceptibility to Type 1 Diabetes","volume":"174","author":"Wagner","year":"2005","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jneuroim.2005.06.015","article-title":"Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis","volume":"167","author":"Suzuki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/1531-8249(200010)48:4<603::AID-ANA6>3.0.CO;2-1","article-title":"Normalization of Elevated CD4\u2212\/CD8\u2212 (Double-Negative) T Cells after Thymectomy Parallels Clinical Remission in Myasthenia Gravis Associated with Thymic Hyperplasia but Not Thymoma","volume":"48","author":"Reinhardt","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1073\/pnas.121169698","article-title":"Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse","volume":"98","author":"Shi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","article-title":"Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia","volume":"175","author":"Liu","year":"2005","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","article-title":"Requirement for V\u03b114 NKT Cells in IL-12-Mediated Rejection of Tumors","volume":"278","author":"Cui","year":"1997","journal-title":"Science"},{"key":"ref_101","first-page":"195","article-title":"Research on the Influence of \u03b1-GalCer Activating Experimental Autoimmune Myasthenia Gravis Mice NKT Cells at Different Times on Myasthenia Gravis","volume":"29","author":"Wang","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: An innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1531","article-title":"\u03b1-Galactosylceramide therapy for autoimmune diseases: Prospects and obstacles","volume":"5","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal Models of Myasthenia Gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon \u03b3 (IFN-\u03b3) Is Necessary for the Genesis of Acetylcholine Receptor\u2013induced Clinical Experimental Autoimmune Myasthenia gravis in Mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 Syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.72.6.767","article-title":"Anti-GT1a IgG in Guillain-Barre syndrome","volume":"72","author":"Koga","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1020280201809","article-title":"A new aspect in glycolipid biology: Glycosphingolipids as antigens recognized by T lymphocytes","volume":"27","author":"Donda","year":"2002","journal-title":"Neurochem. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4049\/jimmunol.180.1.39","article-title":"Cutting Edge: Guillain-Barr\u00e9 Syndrome-Associated IgG Responses to Gangliosides Are Generated Independently of CD1 Function in Mice","volume":"180","author":"Matsumoto","year":"2008","journal-title":"J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2018.11.008","article-title":"Sulfatides ameliorate experimental autoimmune neuritis by suppressing Th1\/Th17 cells","volume":"326","author":"Wang","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fimmu.2018.00519","article-title":"Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Rizzo, C., La Barbera, L., Pizzo, M.L., Ciccia, F., Sireci, G., and Guggino, G. (2019). Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215435"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9520\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:26Z","timestamp":1760165666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":113,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22179520"],"URL":"https:\/\/doi.org\/10.3390\/ijms22179520","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}